AVGO compared with VRTX: revenue, margins and what each company keeps, and the suppliers and customers both name

AVGOBroadcom Inc.

Mkt capRevenueRevenue

VRTXVertex Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

AVGOBroadcom Inc.

VRTXVertex Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AVGO

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±6.8%▼−2.74%×0.40

Q2 FY26±7.5%▼−12.59%×1.68

Q1 FY26±6.5%▲+4.80%×0.74

Q4 FY25±5.7%▼−11.43%×2.00

VRTX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±4.9%▼−4.05%×0.82

Q2 FY26±5.2%▲+1.70%×0.33

= impliedAVGO realized, solidVRTX realized, hatchedOne scale, both sides: full bar = 13%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.4%

▼−1.28%

×0.24

Feb 13 '26±6.0%▲+5.69%×0.95

AVGOBroadcom Inc.

293.50· pre 305.10· delayed

Mkt cap$1.6TRevenue$29.6BQ3 FY26Revenue$63.9BFY25

VRTXVertex Pharmaceuticals Inc

542.37· pre 535.00· delayed

Pre-marketNov 6 '26delayed

Mkt cap$139.2BRevenue$3.4BQ3 FY26Revenue$12.0BFY25

Compare

Pre-marketNov 6 '26delayed

AVGOBroadcom Inc.

VRTXVertex Pharmaceuticals Inc

293.50pre 305.10delayed

Price

542.37pre 535.00delayed

$1.6T

Mkt cap

$139.2B

Q3 FY26$29.6B

Revenue

$3.4BQ3 FY26

FY25$63.9B

Revenue

$12.0BFY25

AVGO293.50vsVRTX542.37Pre-marketNov 6 '26delayed